Roche Holding AG (RHHBY)
30.91
+0.50
(+1.64%)
USD |
OTCM |
Apr 22, 16:00
Roche Gross Profit (TTM): 49.38B for Dec. 31, 2023
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 49.38B |
June 30, 2023 | 47.94B |
December 31, 2022 | 47.81B |
June 30, 2022 | 48.36B |
December 31, 2021 | 47.10B |
June 30, 2021 | 46.70B |
December 31, 2020 | 45.15B |
June 30, 2020 | 43.82B |
December 31, 2019 | 43.27B |
June 30, 2019 | 41.35B |
December 31, 2018 | 39.96B |
June 30, 2018 | 38.12B |
December 31, 2017 | 35.61B |
June 30, 2017 | 34.80B |
December 31, 2016 | 34.90B |
June 30, 2016 | 34.46B |
December 31, 2015 | 33.83B |
June 30, 2015 | 35.40B |
Date | Value |
---|---|
December 31, 2014 | 36.80B |
June 30, 2014 | 38.30B |
December 31, 2013 | 37.77B |
June 30, 2013 | 36.42B |
December 31, 2012 | 35.70B |
June 30, 2012 | 33.95B |
December 31, 2011 | 34.37B |
June 30, 2011 | 33.87B |
December 31, 2010 | 32.77B |
June 30, 2010 | 32.90B |
December 31, 2009 | 32.30B |
June 30, 2009 | 29.50B |
December 31, 2008 | 29.38B |
June 30, 2008 | 30.41B |
December 31, 2007 | 27.39B |
June 30, 2007 | 24.31B |
December 31, 2006 | 23.22B |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
41.35B
Minimum
Jun 2019
49.38B
Maximum
Dec 2023
46.09B
Average
46.90B
Median
Gross Profit (TTM) Benchmarks
Novartis AG | 36.60B |
Pfizer Inc | 33.54B |
ADC Therapeutics SA | 67.03M |
Novo Nordisk A/S | 28.52B |
AC Immune SA | -- |